fbpx

QQQ
-4.48
382.79
-1.18%
BTC/USD
+ 247.49
47985.31
+ 0.52%
DIA
-2.49
350.67
-0.72%
SPY
-5.78
452.95
-1.29%
TLT
-0.72
150.61
-0.48%
GLD
-0.25
164.28
-0.15%

Cantor Fitzgerald: Nevada Cannabis Sales Reach Record High, But There Is Still Room To Grow

June 23, 2021 8:54 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Cantor Fitzgerald: Nevada Cannabis Sales Reach Record High, But There Is Still Room To Grow

Although cannabis businesses were deemed essential across many states during the COVID-19 pandemic, the global crisis still affected the industry. Now, as the pandemic is seemingly coming under control and things are slowly starting to get back to normal, we can expect to see changes in market trends as well.

Cantor Fitzgerald’s Pablo Zuanic looked at those trends in the state of Nevada where adult-use cannabis was legalized in 2017 and sales began in July of that year. In 1998 and 2000, a pair of ballot measures legalized medical marijuana.

Record Sales, High Annual Revenues Per Store 

Cannabis sales hit record highs in March of this year, $97 million, with more growth expected as tourist activities begin to pick up, Zuanic noted, though he pointed out that visitor volumes are still around 30% lower than April 2019 levels.

This appears to signal a positive economic outlook for both retailers and vertically integrated operators, with annual revenue per store earning close to $15 million – numbers, which are second only to Illinois where annual revenue per store is more than $20 million. Furthermore, Nevada's affordable wholesale prices are some 45% lower than those in Illinois and Massachusetts.

“On the flipside, grower economics are likely below average,” Zuanic said, adding that Nevada hosts many large independent and privately-held retail operators, unlike other states. Nevada, which accepts out-of-state medical cards, now permits in-store shopping (with masks) and has delivery and curbside pick-up. 

Ayr Wellness And Green Thumb Lead The Pack 

Among the companies covered by Cantor Fitzgerald, Ayr Wellness (OTCQX:AYRWF) and Green Thumb Industries (OTCQX:GTBIF) account for most of the cannabis sales in Nevada – 20% and 10%, respectively. Green Thumb runs seven stores while Ayr Wellness owns six.

Another notable cannabis company in the market is Planet 13 (PLNHF), which currently generates 100% of its sales in Nevada. Curaleaf Holdings (OTCQX:CURLF) and MedMen Enterprises  (OTCQX:MMNFF) have two stores each.

In conclusion, Zuanic explained that the leading multistate operators have underperformed the overall markets due to delays facing the cannabis federal legislation package, AKA the Schumer Bill, although he noted that “demand for the US cannabis industry continues to grow.”

Photo by Wesley Gibbs on Unsplash

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Cantor Reaffirms Overweight Rating On Cresco Stock Post Earnings Based On The Company's Franchise Strength

Cantor Reaffirms Overweight Rating On Cresco Stock Post Earnings Based On The Company's Franchise Strength

Vertically integrated cannabis company Cresco Labs Inc. read more
Why Cannabis MSOs Will 'Outperform S&P 500' In 2021

Why Cannabis MSOs Will 'Outperform S&P 500' In 2021

Most multistate cannabis operators will outperform the S&P500 in the year ahead, according to Cantor Fitzgerald analyst Pablo Zuanic. read more
Can Past Medical Cannabis Sales Predict Rec Sales?

Can Past Medical Cannabis Sales Predict Rec Sales?

New Jersey is expected to start recreational cannabis sales either later this year or early next. Until then, it's not know what the combined med+rec sales will be, but Cantor Fitzgerald analyst Pablo Zuanic has a rough idea. He decided to take a look at the numbers in other states to help forecast what can be expected from the Garden State. read more
Florida's Medical Cannabis Market Remains 'Underpenetrated' Versus Rivals, Analyst Says

Florida's Medical Cannabis Market Remains 'Underpenetrated' Versus Rivals, Analyst Says

The Florida cannabis market is "quickly consolidating" and, while sequential growth has slowed, fourth-quarter flower volumes spiked 190%, according to Cantor Fitzgerald. The Thesis: "The state’s med market remains underpenetrated vs. other med markets (one-third AZ per cap)," analyst Pablo Zuanic wrote in the note. read more